4-氯-6-甲氧基-7-[3-(4-吗啉)丙氧基]喹唑啉
![4-氯-6-甲氧基-7-[3-(4-吗啉)丙氧基]喹唑啉结构式](https://image.chemsrc.com/caspic/167/196195-13-8.png)
4-氯-6-甲氧基-7-[3-(4-吗啉)丙氧基]喹唑啉结构式
|
常用名 | 4-氯-6-甲氧基-7-[3-(4-吗啉)丙氧基]喹唑啉 | 英文名 | 4-[3-(4-chloro-6-methoxyquinazolin-7-yl)oxypropyl]morpholine |
|---|---|---|---|---|
| CAS号 | 196195-13-8 | 分子量 | 337.80100 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C16H20ClN3O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 4-氯-6-甲氧基-7-[3-(4-吗啉)丙氧基]喹唑啉 |
|---|---|
| 英文名 | 4-[3-(4-chloro-6-methoxyquinazolin-7-yl)oxypropyl]morpholine |
| 英文别名 | 更多 |
| 分子式 | C16H20ClN3O3 |
|---|---|
| 分子量 | 337.80100 |
| 精确质量 | 337.11900 |
| PSA | 56.71000 |
| LogP | 2.33080 |
|
~87%
4-氯-6-甲氧基-7-[3-... 196195-13-8 |
| 文献：AstraZeneca AB Patent: EP1119567 B1, 2005 ; Location in patent: Page/Page column 27 ; |
|
~60%
4-氯-6-甲氧基-7-[3-... 196195-13-8 |
| 文献：AstraZeneca AB Patent: US7235559 B1, 2007 ; US 7235559 B1 |
|
~%
详细
|
| 文献：Hennequin, Laurent Francois Andre; Ple, Patrick; Lambert, Christine Marie Paul Patent: US2004/34046 A1, 2004 ; |
|
~%
4-氯-6-甲氧基-7-[3-... 196195-13-8 |
| 文献：Ple, Patrick A.; Green, Tim P.; Hennequin, Laurent F.; Curwen, Jon; Fennell, Michael; Allen, Jack; Lambert-Van Der Brempt, Christine; Costello, Gerard Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 871 - 887 |
|
~%
4-氯-6-甲氧基-7-[3-... 196195-13-8 |
| 文献：Ple, Patrick A.; Green, Tim P.; Hennequin, Laurent F.; Curwen, Jon; Fennell, Michael; Allen, Jack; Lambert-Van Der Brempt, Christine; Costello, Gerard Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 871 - 887 |
|
~%
4-氯-6-甲氧基-7-[3-... 196195-13-8 |
| 文献：Cai, Jin; Sun, Min; Wu, Xiaoqing; Chen, Junqing; Wang, Peng; Zong, Xi; Ji, Min European Journal of Medicinal Chemistry, 2013 , vol. 63, p. 702 - 712 |
| Quinazoline,4-chloro-6-methoxy-7-[3-(4-morpholinyl)propoxy] |
| 4-chloro-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazoline |
| 4chloro-6-methoxy-7-(3-morpholinopropoxy)quinazoline |
